CSK and breast carcinoma: Specifically, increases in aromatase activity and estradiol secretion are regulated by c-Src kinase-catalysed tyrosine phosphorylation [20] and inhibits in aromatase activity by protein tyrosine phosphatase 1B in breast cancer cells [39].